期刊： ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023; 67 (2)
Phenotypic heterogeneity is crucial to bacterial survival and could provide insights into the mechanism of action (MOA) of antibiotics, especially tho......
期刊： ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023; 67 (2)
Vancomycin-induced kidney injury is common, and outcomes in humans are well predicted by animal models. This study employed our translational rat mode......
期刊： ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023; 67 (4)
Valganciclovir, the ganciclovir prodrug, is an antiviral agent used to prevent cytomegalovirus infection in renal transplant children. Therapeutic dru......
期刊： ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023; 67 (4)
Mycobacterium abscessus (Mabs) is an emerging nontuberculosis mycobacterial (NTM) pathogen responsible for a wide variety of respiratory and cutaneous......
期刊： ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023; 67 (5)
Candida auris represents an urgent health threat. Here, we identified atazanavir as a potent drug capable of resensitizing C. auris clinical isolates ......
期刊： ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023; 67 (7)
The emergence of the Omicron variant of SARS-CoV-2 represented a challenge to the treatment of COVID-19 using monoclonal antibodies. Only Sotrovimab m......
期刊： ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023; 67 (7)
Infections caused by extensively drug-resistant Pseudomonas aeruginosa are difficult to treat due to limited effective treatment options. In this issu......
期刊： ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023; 67 (8)
In 2021, Klebsiella pneumoniae sequence type 307 (ST307) strains causing pulmonary and bloodstream infections identified in a hospital in Rome, Italy,......
期刊： ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023; ()
This commentary explores the convergence of precision health and evolving technologies, including the critical role of artificial intelligence (AI) an......
期刊： ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023; ()
SPR206 is a novel polymyxin derivative with potent in vitro activity against susceptible and multidrug-resistant strains of Acinetobacter baumannii, P......
期刊： ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023; ()
We previously conducted a multicenter surveillance study on Candida epidemiology and antifungal resistance in Madrid (CANDIMAD study; 2019-2021), dete......
期刊： ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023; ()
Variable pharmacokinetics of rifampin in tuberculosis (TB) treatment can lead to poor outcomes. Urine spectrophotometry is simpler and more accessible......
期刊： ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023; 67 (3)
Anti-SARS-CoV-2 immunoglobulin (human) investigational product (COVID-HIGIV) is a purified immunoglobulin preparation containing SARS-CoV-2 polyclonal......
